Adagio Medical Holdings, Inc (ADGM) Fair Value 2026

ADGM · Medical Devices ·

By CirclFi Research Team · Data from SEC EDGAR, FRED & GDELT

Quality Score

5.7 /10

32 fundamental signals · 5 models active

Value Trap Risk

SAFE (11/100)

Quick Summary — As of 2026-07-13, Adagio Medical Holdings, Inc (ADGM) trades at $0.57, approximately 373% above CirclFi’s Bayesian DCF fair value of $0.12. QOC: 5.7/10. Value Trap Risk: 11/100 (SAFE). 5/13 models active.

Key Facts

Ticker
ADGM
Price
$0.57
Quality Score
5.7/10
Value Trap Risk
11/100
Models Active
5/13
Last Updated
Strength: CUCE Ensemble suggests +150.8% upside with 6% confidence
Risk: Limited model coverage (5/13) may reduce confidence

Valuation Matrix

5 Intrinsic Value Models vs. Current Price ($0.57)

Core Models (Unlocked)
Model Fair Value Upside
Bayesian DCF
Low Conviction
$0.12 -78.9%
CUCE Ensemble
Low Conviction
$1.43 +150.8%

Unlock the Full Matrix

Access 3 additional models including ML-RIV, PWERM, and more.

$1.30 / day

Billed monthly ($39/mo) or annually ($299/yr)

Unlock All 5 Models →

Cancel anytime · No contracts · Instant access

What Is Adagio Medical Holdings, Inc (ADGM) Worth in 2026?

According to the CirclFi Deep Alpha Valuation Engine, Adagio Medical Holdings, Inc's intrinsic value is estimated at $0.96, suggesting a +68.5% average upside from the current price of $0.57. While 3 models see room for appreciation, model agreement is not unanimous as 2 models flag potential overvaluation. Model dispersion is worth noting: PWERM targets $1.91 (+233.8%), versus Regime Cross at $0.01 (-98.2%). This +332.1% range highlights the importance of multi-model analysis rather than relying on any single methodology.

What Do the Models Say About ADGM?

5 of 13 models are currently active for ADGM. Of these, 3 models suggest upside while 2 models suggest overvaluation. The Bayesian DCF estimates ADGM's intrinsic value at $0.12, implying -78.9% downside from the current price. See which stocks rank higher →

How Does ADGM Rank in Medical Devices?

Among 10 Medical Devices stocks, ADGM ranks #6 by Quality of Company score. CirclFi's QOC score of 5.7/10 evaluates 32 fundamental signals. A score of 5.7 reflects mixed fundamentals.

Within the Medical Devices space, Adagio Medical Holdings, Inc competes in an environment where patent cliff exposure often separates market leaders from laggards. Understanding these industry-specific dynamics is essential context for interpreting our model outputs.

Is ADGM a Value Trap?

CirclFi's Value Trap algorithm assigns ADGM a score of 11/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →

Multi-Model Methodology

5 of 13 models are active for Adagio Medical Holdings, Inc. Limited activation may indicate insufficient history. Each model applies a fundamentally different valuation philosophy. See the complete methodology →

According to the CirclFi Quality of Company (QOC) framework, which evaluates 32 signals including margin stability, revenue growth trajectory, leverage, and free cash flow generation, Adagio Medical Holdings, Inc is rated at 5.7/10. This solid-tier score maintains reasonable quality metrics with some areas for improvement.

The gap between the most bullish and bearish model spans +332.1% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →

Data Sources & Confidence

Every ADGM valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →

Across ADGM's 5 active models, average confidence is 25%. Lower confidence may reflect limited history or high volatility.

CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →

This analysis is produced by the CirclFi Valuation Engine using quantitative models applied to SEC EDGAR filings, public market feeds, and FRED macroeconomic indicators. It is not financial advice.

Read the full investment analysis: Should You Buy Adagio Medical Holdings, Inc Stock in 2026? →

Bull case, bear case, risk factors & peer comparison — updated daily

Which Similar Medical Devices Stocks Should You Also Analyze?

8 related Medical Devices stocks with 13-model coverage

Read investment analysis: ABT · AORT · AHCO · APYX · AIDX

Frequently Asked Questions About Adagio Medical Holdings, Inc

What is Adagio Medical Holdings, Inc's intrinsic value in 2026?

Based on CirclFi's 13-model analysis, Adagio Medical Holdings, Inc (ADGM) has multiple fair value estimates. The Bayesian DCF model runs 10,000 Monte Carlo simulations with jump-diffusion to estimate intrinsic value at $0.12. The Quality of Company score is 5.7/10 across 32 fundamental signals. All models use SEC EDGAR filings updated daily. See our methodology page for how each model works.

Is ADGM overvalued or undervalued right now?

At $0.57, 3 of 5 active models suggest ADGM may be undervalued, while 2 indicate potential overvaluation. The assessment depends on which methodology best fits Adagio Medical Holdings, Inc's business model in Medical Devices.

What does a Quality of Company score of 5.7 mean for ADGM?

Adagio Medical Holdings, Inc's QOC of 5.7/10 reflects 32 fundamental signals: profitability margins, revenue growth consistency, balance sheet leverage, free cash flow generation, and capital allocation efficiency. Scores between 5-7 reflect moderate fundamentals with areas for improvement.

How many valuation models does CirclFi run on ADGM?

CirclFi analyzes ADGM with 13 institutional-grade models daily: Bayesian DCF (Monte Carlo + jump-diffusion), EPV (Greenwald zero-growth), EROIC Spread (McKinsey reinvestment), First Chicago (3-scenario), Markov DDM (regime-switching), ML-RIV (machine learning residual income), Dynamic NAV (asset-based), PWERM (option-theoretic), Regime Cross-Sectional (relative), Sentiment SOTP (hybrid), CUCE Ensemble (meta-model), FTNN Topology (neural network), and RCMH-DCF (conditional regime). Currently 5 of 13 are active for this stock. Read the full methodology →

Is ADGM a value trap in 2026?

Adagio Medical Holdings, Inc's Value Trap score is 11/100 (SAFE). This low score indicates the current valuation is not artificially depressed by fundamental deterioration, suggesting genuine opportunity rather than a trap. Browse stocks by value-trap risk →

You’ve done the research. Don’t stop at half the picture.

Stop collecting opinions. Let 5 mathematical frameworks give you clarity on ADGM.

Unlock All 5 Fair Values — $39/mo

Cancel anytime · Less than a cup of coffee · Instant access